StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > New Senior Leadership position coming - CIO

<< Previous

Bullboard Posts

Next >>

Post by LithLoveron Dec 06, 2021 5:20pm

295 Views

Post# 34203926

New Senior Leadership position coming - CIO

First Matt as CFO/COO and now a CIO. Tripp is building out a senior leadership team. It's all about execution now. More hub and spoke locations for Aristotle to be announced soon.

Posted 5 hours ago:

Chief Information Officer

StageZero Life Sciences, Inc. - Baltimore, MD

$100,000 - $150,000 a year

<< Previous

Bullboard Posts

Next >>

Canadian artificial intelligence ETFs